If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.25    0.00 (0.00%)
Bid:
0.20
Ask:
0.30
Spread: 0.10 (50.00%)
Market Cap: £1.31m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

Rule 8.3- EXPRO

27 Jun 2008 12:41

RNS Number : 7326X
UBS AG
27 June 2008
 

ïŧŋ

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

 

1. KEY INFORMATION

Name of person dealing (Note 1)

UBS AG London Branch

Company dealt in

Expro International Group Plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ord 10p

Date of dealing

26 JUNE 2008

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number 

(%)

Number

(%)

(1) Relevant securities 

625,376

0.57%

0

0.00%

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

625,376

0.57%

0

0.00%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

(c) Rights to subscribe (Note 3)

 Class of relevant security:

Details

3. DEALINGS (Note 4)

 (a) Purchases and sales

 

Purchase/sale

Number of securities

Price per unit (Note 5)

SALE

4658

1610 PENCE

SALE

4655

1611

SALE

73059

1611

SALE

964

1611

SALE

48642

1611

SALE

4655

1611

PURCHASE

4655

1611

SALE

5000

1611

SALE

10521

1611

SALE

30000

1611

SALE

218

1611

PURCHASE

852

1611

SALE

5000

1611

SALE

782

1611

SALE

4218

1611

SALE

10000

1611

SALE

40000

1611

SALE

40000

1611

SALE

14000

1611

SALE

36000

1611

SALE

50000

1611

SALE

25000

1611

SALE

5900

1611

SALE

100000

1611

PURCHASE

850

1611

PURCHASE

150

1611

SALE

850

1611

SALE

150

1611

SALE

50000

1611

SALE

9700

1611

SALE

39300

1611

SALE

132492

1611

SALE

2500

1612

SALE

1467

1612

SALE

1467

1612

SALE

4652

1612

SALE

10998

1612

SALE

14000

1612

SALE

3030

1612

SALE

1000

1612

SALE

92491

1612

SALE

30000

1612

SALE

9479

1612

SALE

30000

1613

SALE

1576

1613

SALE

18424

1613

PURCHASE

4649

1613

SALE

4649

1613

SALE

32000

1613

SALE

4649

1613

SALE

13351

1613

SALE

1510

1613

PURCHASE

4646

1614

PURCHASE

4646

1614

SALE

4646

1614

SALE

2000

1614

PURCHASE

4643

1615

PURCHASE

4643

1615

PURCHASE

91

1617

PURCHASE

386

1617

PURCHASE

964

1620

PURCHASE

800

1620

SALE

2690

1620

SALE

3546

1620

SALE

964

1620

SALE

856

1620

SALE

800

1620

SALE

3546

1620

SALE

459

1620

SALE

459

1620

SALE

3546

1620

SALE

3546

1620

SALE

459

1620

SALE

1511

1620

SALE

3546

1620

SALE

3546

1620

SALE

3546

1620

SALE

459

1620

SALE

1542

1622

SALE

459

1625

SALE

5000

1625

SALE

964

1626

PURCHASE

1077

1628

SALE

209

1629

PURCHASE

584

1630

SALE

1843

1630

SALE

35

1630

SALE

177

1630

SALE

249

1630

PURCHASE

445

1630

PURCHASE

163

1631

SALE

618

1631

PURCHASE

69

1632

PURCHASE

920

1632

SALE

975

1632

SALE

362

1632

SALE

552

1632

SALE

137

1633

SALE

607

1633

PURCHASE

850

1633

SALE

850

1633

PURCHASE

100

1633

PURCHASE

186

1633

PURCHASE

200

1634

PURCHASE

821

1634

PURCHASE

361

1634

SALE

300

1634

TOTAL PURCHASES

37,751

TOTAL SALES

1,078,011

 

(b) Derivatives transactions (other than options)

Product name, e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5) 

(d) Other dealings (including new securities) (Note 4)

 Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

â€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķ

â€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķâ€Ķ

Is a Supplemental Form 8 attached? (Note 9) NO

 

Date of disclosure

27 JUNE 2008

Contact name

NIMISHA SACHDEV

Telephone number

020 7567 8762

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETUBSARWRRNUAR
Date   Source Headline
2nd Mar 20077:30 amRNSDisposal
22nd Feb 20074:45 pmRNSHolding(s) in Company
20th Feb 20074:14 pmRNSHolding(s) in Company
31st Jan 20074:00 pmRNSTotal Voting Rights
29th Jan 20078:40 amRNSHolding(s) in Company
19th Jan 20074:00 pmRNSTotal Voting Rights
15th Jan 20074:28 pmRNSHolding(s) in Company
10th Jan 20072:24 pmRNSHolding(s) in Company
4th Jan 200712:29 pmRNSHolding(s) in Company
29th Dec 20067:00 amRNSTotal Voting Rights
20th Dec 20068:27 amRNSDirectorate Change
7th Dec 20065:19 pmRNSHolding(s) in Company
30th Nov 20066:15 pmRNSResults of Secondary Placing
30th Nov 20065:56 pmRNSAcquisition
30th Nov 20065:52 pmRNSOrdinary share placing
30th Nov 20067:00 amRNSInterim Results
23rd Nov 20065:20 pmRNSHolding(s) in Company
14th Nov 20062:13 pmRNSHolding(s) in Company
3rd Nov 200610:57 amRNSNotice of Results
29th Sep 20065:12 pmRNSDirector/PDMR Shareholding
27th Sep 20064:39 pmRNSDirector/PDMR Shareholding
25th Sep 20067:01 amRNSTrading Statement
19th Sep 20067:01 amRNSInvestor Visit
14th Sep 20064:52 pmRNSDirector/PDMR Shareholding
5th Sep 20063:31 pmRNSHolding(s) in Company
21st Aug 20063:34 pmRNSBlocklisting Interim Review
1st Aug 20063:14 pmRNSHolding(s) in Company
1st Aug 20067:00 amRNSCompletion of Acquisition
26th Jul 200610:03 amRNSResults of Rights Issue
24th Jul 20067:01 amRNSAntitrust Approvals
19th Jul 20065:54 pmRNSDirector/PDMR Shareholding
19th Jul 20065:50 pmRNSDirector/PDMR Shareholding
14th Jul 20064:07 pmRNSHolding(s) in Company
10th Jul 20064:22 pmRNSDirector/PDMR Shareholding
10th Jul 20064:22 pmRNSDirector/PDMR Shareholding
10th Jul 20064:20 pmRNSDirector/PDMR Shareholding
10th Jul 20064:19 pmRNSDirector/PDMR Shareholding
10th Jul 20064:17 pmRNSHolding(s) in Company
10th Jul 20064:16 pmRNSHolding(s) in Company
4th Jul 20068:44 amRNSAdmission of Nil Paid Rights
3rd Jul 20064:09 pmRNSResult of EGM
30th Jun 200612:21 pmRNSHolding(s) in Company
27th Jun 20066:09 pmRNSAnnual Information Update
14th Jun 20065:39 pmRNSProspectus and Circular
14th Jun 20067:38 amRNSAcquisition
8th Jun 20064:29 pmRNSAnnual Report and Accounts
2nd Jun 20069:00 amRNSInvestor Visit
31st May 20067:02 amRNSFinal Results - Part 2
31st May 20067:02 amRNSRe Contract
31st May 20067:02 amRNSFinal Results - Part 1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.